• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Prils Market Size

    ID: MRFR/HC/6223-CR
    153 Pages
    Kinjoll Dey
    April 2019

    Prils Market Research Report Information by Type (Ramipril, Quinapril, Cilazapril, & Benazepril), Application (Hypertension, Heart Failure, & Chronic Kidney Disorders), & Region (Americas, Europe, Asia-Pacific & the Middle East & Africa) - Global Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Prils Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Prils Size

    Prils Market Growth Projections and Opportunities

    The global prils market is all about active pharmaceutical ingredients (API), which are like the essential building blocks of medicines. These APIs are biologically active substances that play a crucial role in various medications. Different APIs have different properties, and they are used by the pharmaceutical, biotech, and nutritional industries to create new and effective products. The market is driven by several important factors, such as the increasing occurrence of heart diseases, hypertension, and kidney-related problems. Additionally, the growing population of older individuals, the rising importance of generic drugs, and the overall growth of the biopharmaceuticals industry contribute to the market's expansion. On the flip side, some challenges hinder the growth of the prils market. Unfavorable drug price control policies in many countries pose a challenge. There is also an increasing issue of counterfeit drugs entering the market, which can be harmful. Additionally, the complex procedures for renewing licenses can be a hurdle for market growth. Despite these challenges, the prils market continues to evolve and adapt to meet the needs of the pharmaceutical and related industries. Understanding the prils market involves recognizing the significance of APIs, which act as the active and essential components in medications. These APIs are vital in creating drugs that address various health issues, particularly those related to the heart, blood pressure, and kidneys. The demand for such medications is on the rise due to the increasing prevalence of health conditions and the growing aging population worldwide. One of the driving forces behind the growth of the prils market is the increasing incidence of heart diseases, hypertension, and kidney-related problems. These health issues have become more prevalent, necessitating the development of effective medications containing prils to address these concerns. The rise in the aging population is also a significant factor contributing to the market's expansion. As people age, they may experience various health issues, creating a demand for pharmaceutical products that contain prils.

    Prils Market Size Graph

    Market Summary

    The Global Prils Market is projected to grow from 3.15 USD Billion in 2024 to 5.72 USD Billion by 2035, reflecting a robust growth trajectory.

    Key Market Trends & Highlights

    Prils Key Trends and Highlights

    • The market is expected to achieve a compound annual growth rate (CAGR) of 5.58% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 5.72 USD Billion, indicating substantial growth potential.
    • In 2024, the market is valued at 3.15 USD Billion, laying a strong foundation for future expansion.
    • Growing adoption of innovative healthcare solutions due to increasing prevalence of chronic diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 3.15 (USD Billion)
    2035 Market Size 5.72 (USD Billion)
    CAGR (2025-2035) 5.58%
    Largest Regional Market Share in 2024 south_america)

    Major Players

    Lupin, Pfizer, Mylan N.V., F. Hoffman-L Roche, Novartis AG, Aurobindo Pharma, Sun Pharmaceuticals, Canadian Pharmaceuticals, Manus Aktteva Biopharma LLP, Hoffman La Roche, Boehringer Ingelheim International Gmbh, Teva Pharmaceutical Industries

    Market Trends

    The global Prils market appears to be experiencing a notable shift towards innovative formulations and personalized medicine, reflecting a growing demand for tailored therapeutic solutions.

    U.S. Food and Drug Administration (FDA)

    Prils Market Market Drivers

    Rising Demand for Pharmaceuticals

    The Global Prils Market Industry experiences a notable surge in demand driven by the increasing prevalence of hypertension and cardiovascular diseases. As healthcare systems worldwide prioritize the management of these conditions, the market for Prils is projected to reach 3.15 USD Billion in 2024. This growth is indicative of a broader trend where pharmaceutical companies are focusing on developing innovative formulations and delivery methods for Prils, thereby enhancing patient adherence and treatment outcomes. The emphasis on preventive healthcare further propels this demand, suggesting a robust future for the Global Prils Market Industry.

    Market Segment Insights

    Regional Insights

    Key Companies in the Prils Market market include

    Industry Developments

      • A global pharmaceutical company Hikal announced its approval by the U.S. Food and Drugs Administration (FDA). Hikal is developing and growing in the market gradually and steadily. It is expected to lead the prils market in forthcoming years.
      • The FDA in the United States of America played a crucial role in the increasing the sales worldwide. The organisation approved several drugs related to cardiovascular treatments. It helped the manufacturers to develop more drugs at a rapid speed and reach more patients in need.

    Future Outlook

    Prils Market Future Outlook

    The Global Prils Market is projected to grow at a 5.58% CAGR from 2024 to 2035, driven by increasing demand for effective antihypertensive treatments and advancements in pharmaceutical formulations.

    New opportunities lie in:

    • Develop innovative combination therapies to enhance efficacy and patient compliance.
    • Expand distribution channels in emerging markets to capture untapped consumer segments.
    • Invest in digital health solutions to improve patient monitoring and adherence.

    By 2035, the Global Prils Market is expected to achieve robust growth, reflecting evolving healthcare needs and technological advancements.

    Market Segmentation

    By Type

    • Cilazapril
    • Ramipril
    • Benazepril
    • Quinapril

    By Application

    • Others
    • Hypertension
    • Chronic Kidney Disorders
    • Heart Failure

    Recent Developments

    • The FDA in the United States of America played a crucial role in the increasing the sales worldwide. The organisation approved several drugs related to cardiovascular treatments. It helped the manufacturers to develop more drugs at a rapid speed and reach more patients in need.
    • A global pharmaceutical company Hikal announced its approval by the U.S. Food and Drugs Administration (FDA). Hikal is developing and growing in the market gradually and steadily. It is expected to lead the prils market in forthcoming years.

    By Geographical Region

    • The Middle East and Africa (GCC, South Africa, and rest)
    • Europe (Germany, France, Spain, Italy, U.K.)
    • Asia Pacific (India, Japan, China, Australia, and rest)
    • Latin America (Mexico, Brazil, and rest)
    • North America (The U.S. and Canada)

    Key Players in the Prils Market 

    • Teva Pharmaceutical Industries (U.S.)
    • Boehringer Ingelheim International Gmbh (Germany)
    • Hoffman La Roche (Switzerland)
    • Manus Aktteva Biopharma LLP (India)
    • Canadian Pharmaceuticals (Canada)
    • Novartis (Switzerland)
    • Sun Pharmaceuticals (India)
    • Pfizer (U.S.)
    • Aurobindo Pharma (India)
    • Lupin (India)
    • MERCK KGaA (Germany)
    • Mylan N.V. (U.S.)
    • The FDA in the United States of America played a crucial role in the increasing the sales worldwide. The organisation approved several drugs related to cardiovascular treatments. It helped the manufacturers to develop more drugs at a rapid speed and reach more patients in need.
    • A global pharmaceutical company Hikal announced its approval by the U.S. Food and Drugs Administration (FDA). Hikal is developing and growing in the market gradually and steadily. It is expected to lead the prils market in forthcoming years.

    Report Scope

    Report Attribute/Metric Details
      Market Size 2023   USD 2.95 Billion
      Market Size 2024   USD 3.15 Billion
      Market Size 2032   USD 4.93 Billion
    CAGR 5.10% (2024-2032)
    Base Year   2021
    Forecast Period   2024-2032
    Historical Data   2020
    Forecast Units   Value (USD Million)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered Types, end user, Region
    Geographies Covered America, Europe, Asia Pacific, Middle East and Africa
    Key Vendors Mylan N.V. (U.S.), MERCK KGaA (Germany), Lupin (India), Aurobindo Pharma (India), Pfizer (U.S.), Sun Pharmaceuticals (India), Novartis (Switzerland), Canadian Pharmaceuticals (Canada), Manus Aktteva Biopharma LLP (India), Hoffman La Roche (Switzerland), Boehringer Ingelheim International Gmbh (Germany), Teva Pharmaceutical Industries (U.S.)

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    At what CAGR is the prils market projected to grow during the forecast period?

    Prils market is projected to grow at a 5.10% CAGR between 2024-2032.

    Which region is expected to dominate the prils market?

    The Americas is expected to dominate the prils market.

    What will be the value of the prils market during the forecast period?

    Prils market is predicted to touch USD 4.93 Billion by 2032.

    What are the major applications of prils?

    Prils are widely used for chronic kidney disorders, heart failure, and hypertension.

    Which factors may limit the prils market growth?

    Rise in counterfeit drugs may limit the prils market growth.

    1. Executive Summary
    2. Market Introduction
      1. Scope of the Study
      2. Research Objective
      3. List of Assumptions
    3. Research Methodology
      1. Research Process
      2. Primary Research
      3. Secondary Research
      4. Market Size Estimation
    4. Market Dynamics
      1. Introduction
      2. Drivers
        1. Growing Pharmaceutical Industry
        2. Growing Prevalence of Chronic Diseases Across the World
        3. Growing Importance of Generic Drugs
      3. Restraints
        1. Stringent Regulatory Policies
        2. Adverse Drug Price Control Policies Across Numerous Countries
      4. Opportunity
        1. Development of New Drugs
      5. Product Pipeline Analysis
        1. Introduction
        2. NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients
        3. Testing Ramipril to Prevent Memory Loss in People with Glioblastoma
        4. Ramipril Treatment of Claudication
        5. Bariatric Surgery and Pharmacokinetics of Ramipril
    5. Market Factor Analysis
      1. Value Chain Analysis
        1. R&D and Designing
        2. Manufacturing
        3. Distribution & Sales
        4. Marketing & Sales
        5. Post-Sales Review
      2. Porter’s Five Forces Model
        1. Bargaining Power of Suppliers
        2. Bargaining Power of Buyers
        3. Threat of New Entrants
        4. Intense Rivalry
      3. Specifications & Purity Requirements
      4. Patent Analysis
        1. Introduction
      5. Regulatory Analysis
    6. Prils Market, by Type
      1. Introduction
      2. Ramapril
      3. Quinapril
      4. Cilazapril
      5. Benazepril
    7. Prils Market, by Application
      1. Introduction
      2. Hypertension
      3. Heart Failure
      4. Chronic Kidney Disorders
    8. Global Prils Market, by Region
      1. Introduction
      2. Americas
    9. Prils Market, by Type Prils Market, by Application
      1. North America
    10. Prils Market, by Type Prils Market, by Application
      1. US
    11. Prils Market, by Type Prils Market, by Application
      1. Canada
    12. Prils Market, by Type Prils Market, by Application
      1. South America
    13. Prils Market, by Type Prils Market, by Application
      1. Europe
    14. Prils Market, by Type Prils Market, by Application
      1. Western Europe
    15. Prils Market, by Type Prils Market, by Application
      1. Germany
    16. Prils Market, by Type Prils Market, by Application
      1. UK
    17. Prils Market, by Type Prils Market, by Application
      1. France
    18. Prils Market, by Type Prils Market, by Application
      1. Italy
    19. Prils Market, by Type Prils Market, by Application
      1. Spain
    20. Prils Market, by Type Prils Market, by Application
      1. Rest of Western Europe
    21. Prils Market, by Type Prils Market, by Application
      1. Eastern Europe
    22. Prils Market, by Type Prils Market, by Application
      1. Asia-Pacific
    23. Prils Market, by Type Prils Market, by Application
      1. Japan
    24. Prils Market, by Type Prils Market, by Application
      1. China
    25. Prils Market, by Type Prils Market, by Application
      1. India
    26. Prils Market, by Type Prils Market, by Application
      1. Australia
    27. Prils Market, by Type Prils Market, by Application
      1. South Korea
    28. Prils Market, by Type Prils Market, by Application
      1. Rest of Asia-Pacific
    29. Prils Market, by Type Prils Market, by Application
      1. Middle East & Africa
    30. Prils Market, by Type Prils Market, by Application
      1. Middle East
    31. Prils Market, by Type Prils Market, by Application
      1. Africa
    32. Prils Market, by Type Prils Market, by Application
    33. Competitive landscape
      1. Introduction
      2. Key developments
    34. Company Profiles
      1. Aurobindo Pharma
        1. Company Overview
        2. Financial Overview
        3. Products/Services Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      2. Lupin
        1. Company Overview
        2. Financial Overview
        3. Products/Services Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      3. Pfizer, Inc.
        1. Company Overview
        2. Financial Overview
        3. Products/Services Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      4. Mylan N.V.
        1. Company Overview
        2. Financial Overview
        3. Products/Services Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      5. F. Hoffmann-La Roche
        1. Company Overview
        2. Financial Overview
        3. Products/Services Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      6. Sun Pharmaceutical Industries Ltd
        1. Company Overview
        2. Financial Overview
        3. Products/Services Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      7. Merck KGaA
        1. Company Overview
        2. Financial Overview
        3. Products/Services Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      8. Manus Aktteva Biopharma LLP
        1. Company Overview
        2. Financial Overview
        3. Products/Services Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      9. Canagen Pharmaceuticals Inc.
        1. Company Overview
        2. Financial Overview
        3. Products/Services Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      10. Novartis AG
        1. Company Overview
        2. Financial Overview
        3. Products/Services Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
    35. Appendix References
    36. Related Reports
    37. List of Tables
    38. LIST OF ASSUMPTIONS
    39. PRIMARY INTERVIEWS
    40. PRILS MARKET: PRODUCT PIPELINE ANALYSIS
    41. PORTER’S FIVE FORCES ANALYSIS: GLOBAL PRILS MARKET
    42. PATENT ANALYSIS FOR GLOBAL PRILS MARKET
    43. GLOBAL PRILS MARKET, BY TYPE,
    44. GLOBAL PRILS MARKET, BY TYPE,
    45. GLOBAL PRILS MARKET, BY TYPE,
    46. GLOBAL PRILS MARKET, FOR RAMAPRIL, BY REGION,
    47. GLOBAL PRILS MARKET, FOR QUINAPRIL, BY REGION,
    48. GLOBAL PRILS MARKET, FOR CILAZAPRIL, BY REGION,
    49. GLOBAL PRILS MARKET, FOR BENAZEPRIL, BY REGION,
    50. GLOBAL PRILS MARKET, BY APPLICATION,
    51. GLOBAL PRILS MARKET, FOR HYPERTENSION, BY REGION,
    52. GLOBAL PRILS MARKET, FOR HEART FAILURE, BY REGION,
    53. GLOBAL PRILS MARKET, FOR CHRONIC KIDNEY DISORDERS, BY REGION,
    54. GLOBAL PRILS MARKET, BY REGION,
    55. AMERICAS: PRILS MARKET, BY REGION,
    56. AMERICAS: PRILS MARKET, BY TYPE,
    57. AMERICAS: PRILS MARKET, BY TYPE,
    58. AMERICAS: PRILS MARKET, BY TYPE,
    59. AMERICAS: PRILS MARKET, BY APPLICATION,
    60. NORTH AMERICA: PRILS MARKET, BY REGION,
    61. NORTH AMERICA: PRILS MARKET, BY TYPE,
    62. NORTH AMERICA: PRILS MARKET, BY APPLICATION,
    63. US: PRILS MARKET, BY TYPE,
    64. US: PRILS MARKET, BY APPLICATION,
    65. CANADA: PRILS MARKET, BY TYPE,
    66. CANADA: PRILS MARKET, BY APPLICATION,
    67. SOUTH AMERICA: PRILS MARKET, BY TYPE,
    68. SOUTH AMERICA: PRILS MARKET, BY APPLICATION,
    69. EUROPE: PRILS MARKET, BY REGION,
    70. EUROPE: PRILS MARKET, BY TYPE,
    71. EUROPE: PRILS MARKET, BY TYPE,
    72. EUROPE: PRILS MARKET, BY TYPE,
    73. EUROPE: PRILS MARKET, BY APPLICATION,
    74. WESTERN EUROPE: PRILS MARKET, BY REGION,
    75. WESTERN EUROPE: PRILS MARKET, BY TYPE,
    76. WESTERN EUROPE: PRILS MARKET, BY APPLICATION,
    77. GERMANY: PRILS MARKET, BY TYPE,
    78. GERMANY: PRILS MARKET, BY APPLICATION,
    79. UK: PRILS MARKET, BY TYPE,
    80. UK: PRILS MARKET, BY APPLICATION,
    81. FRANCE: PRILS MARKET, BY TYPE,
    82. FRANCE: PRILS MARKET, BY APPLICATION,
    83. ITALY: PRILS MARKET, BY TYPE,
    84. ITALY: PRILS MARKET, BY APPLICATION,
    85. SPAIN: PRILS MARKET, BY TYPE,
    86. SPAIN: PRILS MARKET, BY APPLICATION,
    87. REST OF WESTERN EUROPE: PRILS MARKET, BY TYPE,
    88. REST OF WESTERN EUROPE: PRILS MARKET, BY APPLICATION,
    89. EASTERN EUROPE: PRILS MARKET, BY TYPE,
    90. EASTERN EUROPE: PRILS MARKET, BY APPLICATION,
    91. ASIA-PACIFIC: PRILS MARKET, BY REGION,
    92. ASIA-PACIFIC: PRILS MARKET, BY TYPE,
    93. ASIA-PACIFIC: PRILS MARKET, BY TYPE,
    94. ASIA-PACIFIC: PRILS MARKET, BY TYPE,
    95. ASIA-PACIFIC: PRILS MARKET, BY APPLICATION,
    96. JAPAN: PRILS MARKET, BY TYPE,
    97. JAPAN: PRILS MARKET, BY APPLICATION,
    98. CHINA: PRILS MARKET, BY TYPE,
    99. CHINA: PRILS MARKET, BY APPLICATION,
    100. INDIA: PRILS MARKET, BY TYPE,
    101. INDIA: PRILS MARKET, BY APPLICATION,
    102. AUSTRALIA: PRILS MARKET, BY TYPE,
    103. AUSTRALIA: PRILS MARKET, BY APPLICATION,
    104. SOUTH KOREA: PRILS MARKET, BY TYPE,
    105. SOUTH KOREA: PRILS MARKET, BY APPLICATION,
    106. REST OF ASIA-PACIFIC: PRILS MARKET, BY TYPE,
    107. REST OF ASIA-PACIFIC: PRILS MARKET, BY APPLICATION,
    108. MIDDLE EAST & AFRICA: PRILS MARKET, BY REGION,
    109. MIDDLE EAST & AFRICA: PRILS MARKET, BY TYPE,
    110. MIDDLE EAST & AFRICA: PRILS MARKET, BY TYPE,
    111. MIDDLE EAST & AFRICA: PRILS MARKET, BY TYPE,
    112. MIDDLE EAST & AFRICA: PRILS MARKET, BY APPLICATION,
    113. MIDDLE EAST: PRILS MARKET, BY TYPE,
    114. MIDDLE EAST: PRILS MARKET, BY APPLICATION,
    115. AFRICA: PRILS MARKET, BY TYPE,
    116. AFRICA: PRILS MARKET, BY APPLICATION,
    117. MAJOR MANUFACTURERS IN THE GLOBAL PRILS MARKETMARKET
    118. KEY DEVELOPMENTS BY PLAYERS IN THE MARKET
    119. List of Figures
    120. MARKET SYNOPSIS
    121. GLOBAL PRILS MARKET: STRUCTURE
    122. RESEARCH PROCESS
    123. TOP-DOWN AND BOTTOM-UP APPROACHES
    124. MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PRILS MARKET
    125. VALUE CHAIN: GLOBAL PRILS MARKET
    126. GLOBAL PRILS MARKET, BY TYPE,
    127. GLOBAL PRILS MARKET, BY APPLICATION,
    128. GLOBAL PRILS MARKET SHARE, BY REGION,
    129. AMERICAS: PRILS MARKET SHARE, BY REGION,
    130. NORTH AMERICA: PRILS MARKET SHARE, BY REGION,
    131. EUROPE: PRILS MARKET SHARE, BY REGION,
    132. WESTERN EUROPE: PRILS MARKET SHARE, BY REGION,
    133. ASIA-PACIFIC: PRILS MARKET SHARE, BY REGION,
    134. MIDDLE EAST & AFRICA: PRILS MARKET SHARE, BY REGION,
    135. CATEGORY WISE SHARE OF KEY DEVELOPMENTS 74

    Prils Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027